Results 191 to 199 of about 49,496 (199)

L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents

, 2007
Francesco Pinnen, Piera Sozio, Laura Serafina Cerasa, Antonio Iannitelli, Ivana Cacciatore, A. Cocco, Massimo Ricciutelli, Gianfabio Giorgioni, Antonio Di Stefano   +8 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

[Drug information: antiparkinson agents. II. Dopaminergic agents].

Sygeplejersken, 1981
openaire   +1 more source

Treatment of drug-induced extrapyramidal symptoms. (A comparative study of three antiparkinson agents).

, 1960
WALTER KRUSE
openalex  

[CLINICAL EXPERIENCES WITH A NEW ANTIPARKINSON AGENT, AKINETON, WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS CAUSED BY PHENOTHIAZINE DERIVATIVES].

, 1964
Atsuyoshi Mori, Y Yabuki
openalex  

[L-dopa and antiparkinson agents].

Revue medicale de Liege, 1996
openaire   +1 more source

[Drug information: antiparkinson agents].

Sygeplejersken, 1981
openaire   +1 more source

[A new antiparkinson agent. Pergolide].

Ugeskrift for laeger, 1995
openaire   +1 more source

[ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].

Der Nervenarzt, 1996
openaire   +1 more source

[Glutamic acid antagonists as antiparkinson agents?].

Deutsche medizinische Wochenschrift (1946), 1992
openaire   +1 more source